Burcon files preliminary short form prospectus


    VANCOUVER, May 28 /CNW/ - Burcon NutraScience Corporation (TSXV -BU)
("Burcon" or the "Corporation") announced today that it has filed a
preliminary short form prospectus with the securities regulatory authorities
in the Provinces of British Columbia, Alberta, Saskatchewan, Manitoba,
Ontario, New Brunswick and Nova Scotia in connection with a best efforts
offering of common shares of the Corporation (the "Offering"). The net
proceeds of the Offering shall be used for continued research and development
of the soy protein isolate extraction and purification technology
(CLARISOY(TM)), further refining of the canola protein isolate extraction and
purification technology (Puratein(R) and Supertein(TM)), filing new patent
applications and expanding the Company's intellectual property portfolio, and
for general working capital purposes.
    The Offering will be led by Paradigm Capital Inc. with a syndicate
comprised of BMO Capital Markets and Haywood Securities Inc. Final pricing and
determination of the number of common shares to be sold pursuant to the
Offering will occur immediately prior to the filing of the (final) short form
prospectus in respect of the Offering.
    The Offering is subject to regulatory approval including approval of the
TSX Venture Exchange.

    This press release is not an offer to sell or the solicitation of an
offer to buy the securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to qualification or registration
under the securities laws of such jurisdiction. The securities being offered
have not been, nor will they be, registered under the United States Securities
Act of 1933, as amended, and such securities may not be offered or sold within
the United States or to, or for the account or benefit of, U.S. persons absent
registration or an applicable exemption from U.S. registration requirements.

    About Burcon NutraScience

    Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology. We are developing the
world's first commercial canola proteins, Puratein(R) and Supertein(TM) with
unique functional and nutritional attributes, and CLARISOY(TM), a
revolutionary soy protein isolate which is 100% soluble and completely
transparent in acidic solutions. Our team of highly specialized scientists and
engineers work from our own research facility to develop and optimize
environmentally sound technologies. To-date, our patent portfolio consists of
84 issued patents in various countries, including 8 issued U.S. patents, and
well in excess of 200 pending patent applications, 55 of which are U.S. patent

    "Johann F. Tergesen"
    Johann F. Tergesen
    President and Chief Operating Officer

    Neither TSX Venture Exchange nor its Regulation Services Provider (as
    that term is defined in the policies of the TSX Venture Exchange) accepts
    responsibility for the adequacy or accuracy of this release.

    This press release contains forward-looking statements that involve risks
and uncertainties. These forward-looking statements relate to, among other
things, plans and timing for the introduction or enhancement of our products,
statements about future market conditions, supply and demand conditions, and
other expectations, intentions and plans contained in this press release that
are not historical fact. Our expectations regarding the prospect for future
success depend upon our ability to develop and sell products, which we do not
produce today and cannot be sold without further research and development.
When used in this press release, the words "goal", "capital raising",
"intend", "believes" and "potential" and similar expressions, generally
identify forward-looking statements. These statements reflect our current
expectations. They are subject to a number of risks and uncertainties. In
light of the many risks and uncertainties surrounding the development of a
source of protein from canola meal, you should understand that we cannot
assure you that the forward looking statements contained in this press release
will be realized.

For further information:

For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free,
jcheng@burcon.ca, www.burcon.ca; AXINO AG, Sven Olsson, Investor Relations
Europe, AXINO AG, Konigstrasse 26, 70173 Stuttgart, Germany, Tel. +49-711-25
35 92-30, Fax +49-711-25 35 92-33, olsson@axino.de, www.burcon.net

Organization Profile

Burcon NutraScience Corporation

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890